Featured Research

from universities, journals, and other organizations

New imaging advance illuminates immune response in breathing lung

Date:
December 30, 2010
Source:
University of California - San Francisco
Summary:
In a recent study in mice, researchers developed a method to stabilize living lung tissue for imaging without disrupting the normal function of the organ. The method allowed the team to observe, for the first time, both the live interaction of living cells in the context of their environment and the unfolding of events in the immune response to lung injury.

Lung cells marked in the Actin-CFP transgenic mouse (green) are stabilized with an imaging window, and breathing artifacts are removed by averaging 15 video rate frames.
Credit: Created by E. Thornton and M. Looney

Fast-moving objects create blurry images in photography, and the same challenge exists when scientists observe cellular interactions within tissues constantly in motion, such as the breathing lung. In a recent UCSF-led study in mice, researchers developed a method to stabilize living lung tissue for imaging without disrupting the normal function of the organ. The method allowed the team to observe, for the first time, both the live interaction of living cells in the context of their environment and the unfolding of events in the immune response to lung injury.

The finding impacts disease research, the authors say, because the ability to image the lung and other organs with minimum tissue disruption allows scientists to look deeper into the many physiological aspects of injury and diseases like diabetes or cancer.

"The nature of disease is complex, so if scientists can observe in real-time what's happening in tumors or immune responses as they occur, we can find new ways to intervene," said senior author Max Krummel, PhD, UCSF associate professor of Pathology, whose lab developed the new imaging technique for seeing minute details of cellular interaction in tissues.

"We figured out a method for holding cells still enough to image them without interrupting their normal processes. This enabled us to observe cellular events as they happen naturally rather than the usual way, which is to stop the motion of cellular processes in order to photograph them."

The research, published online this week in Nature Methods, includes videos of these immune cell interactions: http://www.nature.com/nmeth/journal/vaop/ncurrent/full/nmeth.1543.html.

To achieve such clear imaging of the fast-moving lung cells, the team developed a custom rig device that applies a gentle amount of suction to the tissue surface, holding the region for viewing inside the range of their microscope. They then used super-fast imaging with a two-photon microscope to photograph the tissue. Footage was taken 30 times each second, revealing the full progression of cellular participants involved in different biological processes -- for example: which cells worked together to mount a response to an injury. With that information, the team was able to identify the function of different cell types.

The fast, two-photon microscopy technique previously was developed by the team to monitor immune cells in the lymph nodes and other biological processes. Two-photon microscopy is a light-based high-resolution imaging technology using infrared pulsed lasers to penetrate deep into tissue layers, capturing details as small as one micron (or one ten-thousandth of a centimeter) in diameter. The study uses custom-built microscopes that the team constructed on-site at UCSF.

With more than 20 previously published articles using microscopy, the team is focused on continuing to improve the ability to observe molecules and cells deep within tissues.

"Imaging tissues or organs is ideally done within the living organism and as noninvasively as possible, but there are many challenges," said Mark R. Looney, MD, co-first author and assistant professor in Medicine and Laboratory Medicine at UCSF.

"Light is absorbed and scattered as it passes through tissue, which degrades image quality. And even anesthetized animals have vascular and respiratory movements, complicating the imaging of dynamic processes. Many of these problems are exacerbated in the lung," said Emily Thornton, co-first author and a graduate student in Krummel's laboratory.

Although the lung is a challenging organ to image, it is the site of several important biological functions useful in the study of diseases. For instance, the lung is where the body's internal systems encounter the outside environment through the inhalation of air, allergens, toxins and pathogens. The lung also is in constant contact with inhaled air and with circulating blood cells.

"As a result of achieving video-rate imaging of events within the lung, we've shown how the immune system behaves during normal function and how tissues are affected in acute lung injury," Looney said. "For other disease processes in other organs, we hope to define how collections of cells participate and how they're organized."

In the future, the team plans to miniaturize the stabilizing rig in order to image live tissue biopsies.

"Many different specialties of clinical scientists and pathologists can use this imaging method to learn how disease progression unfolds, but miniaturizing the rig to image biopsied tissue would be a tremendous improvement," Krummel said. "In real-time, for instance, we can catch how cells interact with tumors and observe whether they promote growth or rejection, and whether medical therapy is working."

Additional UCSF authors include Debasish Sen, PhD. Robb Glenny, MD, and Wayne Lamm contributed to the study from the University of Washington, Seattle.

The study was funded by the NIH, American Asthma Foundation, Sandler Basic Asthma Research Center, National Blood Foundation, National Science Foundation, and the Graduate Research Fellowship Program.


Story Source:

The above story is based on materials provided by University of California - San Francisco. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mark R Looney, Emily E Thornton, Debasish Sen, Wayne J Lamm, Robb W Glenny, Matthew F Krummel. Stabilized imaging of immune surveillance in the mouse lung. Nature Methods, 2010; DOI: 10.1038/nmeth.1543

Cite This Page:

University of California - San Francisco. "New imaging advance illuminates immune response in breathing lung." ScienceDaily. ScienceDaily, 30 December 2010. <www.sciencedaily.com/releases/2010/12/101220142438.htm>.
University of California - San Francisco. (2010, December 30). New imaging advance illuminates immune response in breathing lung. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/12/101220142438.htm
University of California - San Francisco. "New imaging advance illuminates immune response in breathing lung." ScienceDaily. www.sciencedaily.com/releases/2010/12/101220142438.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins